Dr. ID: 6016847

Corinna Albers-Leischner

graph of relations
Affiliations

Publications

  1. 2024
  2. Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis

    Illini, O., Saalfeld, F. C., Christopoulos, P., Duruisseaux, M., Vikström, A., Peled, N., Demedts, I., Dudnik, E., Eisert, A., Hashemi, S. M. S., Janzic, U., Kian, W., Mohorcic, K., Mohammed, S., Silvoniemi, M., Rothschild, S. I., Schulz, C., Wesseler, C., Addeo, A., Armster, K., Itchins, M., Ivanović, M., Kauffmann-Guerrero, D., Koivunen, J., Kuon, J., Pavlakis, N., Piet, B., Sebastian, M., Velthaus-Rusik, J-L., Wannesson, L., Wiesweg, M., Wurm, R., Albers-Leischner, C., Aust, D. E., Janning, M., Fabikan, H., Herold, S., Klimova, A., Loges, S., Sharapova, Y., Schütz, M., Weinlinger, C., Valipour, A., Overbeck, T. R., Griesinger, F., Jakopovic, M., Hochmair, M. J. & Wermke, M., 03.04.2024, In: INT J MOL SCI. 25, 7, 3992.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. 2022
  4. Treatment outcome of atypical EGFR mutations in the German National Network Genomic Medicine Lung Cancer (nNGM)

    Janning, M., Süptitz, J., Albers-Leischner, C., Delpy, P., Tufman, A., Velthaus-Rusik, J-L., Reck, M., Jung, A., Kauffmann-Guerrero, D., Bonzheim, I., Brändlein, S., Hummel, H-D., Wiesweg, M., Schildhaus, H-U., Stratmann, J. A., Sebastian, M., Alt, J., Buth, J., Esposito, I., Berger, J., Tögel, L., Saalfeld, F. C., Wermke, M., Merkelbach-Bruse, S., Hillmer, A. M., Klauschen, F., Bokemeyer, C., Buettner, R., Wolf, J. & Loges, S., 06.2022, In: ANN ONCOL. 33, 6, p. 602-615 14 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  5. NIPA (Nuclear Interaction Partner of ALK) Is Crucial for Effective NPM-ALK Mediated Lymphomagenesis

    Kreutmair, S., Lippert, L. J., Klingeberg, C., Albers-Leischner, C., Yacob, S., Shlyakhto, V., Mueller, T., Mueller-Rudorf, A., Yu, C., Gorantla, S. P., Miething, C., Duyster, J. & Illert, A. L., 13.05.2022, In: FRONT ONCOL. 12, 875117.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  6. 2020
  7. Phosphorylation of Beclin-1 by BCR-ABL suppresses autophagy in chronic myeloid leukemia

    Yu, C., Gorantla, S. P., Müller-Rudorf, A., Müller, T. A., Kreutmair, S., Albers, C., Jakob, L., Lippert, L. J., Yue, Z., Engelhardt, M., Follo, M., Zeiser, R., Huber, T. B., Duyster, J. & Illert, A. L., 05.2020, In: HAEMATOLOGICA. 105, 5, p. 1285-1293 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  8. 2015
  9. Grb10 is involved in BCR-ABL-positive leukemia in mice

    Illert, A. L., Albers, C., Kreutmair, S., Leischner, H., Peschel, C., Miething, C. & Duyster, J., 04.2015, In: LEUKEMIA. 29, 4, p. 858-68 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  10. 2014
  11. GP130 activation induces myeloma and collaborates with MYC

    Dechow, T., Steidle, S., Götze, K. S., Rudelius, M., Behnke, K., Pechloff, K., Kratzat, S., Bullinger, L., Fend, F., Soberon, V., Mitova, N., Li, Z., Thaler, M., Bauer, J., Pietschmann, E., Albers, C., Grundler, R., Schmidt-Supprian, M., Ruland, J., Peschel, C., Duyster, J., Rose-John, S., Bassermann, F. & Keller, U., 12.2014, In: J CLIN INVEST. 124, 12, p. 5263-74 12 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  12. 2013
  13. The secondary FLT3-ITD F691L mutation induces resistance to AC220 in FLT3-ITD+ AML but retains in vitro sensitivity to PKC412 and Sunitinib

    Albers, C., Leischner, H., Verbeek, M., Yu, C., Illert, A. L., Peschel, C., von Bubnoff, N. & Duyster, J., 06.2013, In: LEUKEMIA. 27, 6, p. 1416-8 3 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  14. 2012
  15. Extracellular signal-regulated kinase 2 (ERK2) mediates phosphorylation and inactivation of nuclear interaction partner of anaplastic lymphoma kinase (NIPA) at G2/M

    Illert, A. L., Zech, M., Moll, C., Albers, C., Kreutmair, S., Peschel, C., Bassermann, F. & Duyster, J., 02.11.2012, In: J BIOL CHEM. 287, 45, p. 37997-8005 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  16. SRC is a signaling mediator in FLT3-ITD- but not in FLT3-TKD-positive AML

    Leischner, H., Albers, C., Grundler, R., Razumovskaya, E., Spiekermann, K., Bohlander, S., Rönnstrand, L., Götze, K., Peschel, C. & Duyster, J., 26.04.2012, In: BLOOD. 119, 17, p. 4026-33 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  17. 2011
  18. An RNAi-based system for loss-of-function analysis identifies Raf1 as a crucial mediator of BCR-ABL-driven leukemogenesis

    Albers, C., Illert, A. L., Miething, C., Leischner, H., Thiede, M., Peschel, C. & Duyster, J., 25.08.2011, In: BLOOD. 118, 8, p. 2200-10 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  19. In vitro-established alloantigen-specific CD8+ CTLs mediate graft-versus-tumor activity in the absence of graft-versus-host disease

    Hartmann, N., Leithäuser, F., Albers, C., Duyster, J., Möller, P., Debatin, K-M. & Strauss, G., 05.2011, In: LEUKEMIA. 25, 5, p. 848-55 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  20. 2010
  21. Novel pathway in Bcr-Abl signal transduction involves Akt-independent, PLC-gamma1-driven activation of mTOR/p70S6-kinase pathway

    Markova, B., Albers, C., Breitenbuecher, F., Melo, J. V., Brümmendorf, T. H., Heidel, F., Lipka, D., Duyster, J., Huber, C. & Fischer, T., 04.02.2010, In: ONCOGENE. 29, 5, p. 739-51 13 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review